Riskpilot← Back to searchSign inGet full accessAbbibr doc AB
ABActiveOrg 5590435136Oskarslundsbacken 29 BvMedical specialists activities · NACE 8622Est. 20151 employees
Revenue 2025
SEK 2,7M
+2% vs 2024
EBITDA margin
35.0%
+27% vs 2024
Equity ratio
55.9%
Financial strength
Net profit 2025
SEK 679K
+14% vs 2024
| Revenue | SEK 2,7M | +2% |
| EBITDA | SEK 953K | +27% |
| Net profit | SEK 679K | +14% |
| Total assets | SEK 1,3M | +6% |
| Equity | SEK 753K | +12% |
| Employees | 1 | — |
Legal name
Abbibr doc AB
Org number
5590435136
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
21 december 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är bedriva läkarpraktik med huvudsak inriktning på allmän medicin och därmed förenlig verksamhet.
Address
Oskarslundsbacken 29 Bv
Email
abbasabdi66@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 590 | 2 660 | 2 548 | 2 670 | 2 723 |
| Staff expenses | — | −1 577 | −1 381 | −1 410 | −1 311 |
| EBITDA | 691 | 704 | 885 | 751 | 953 |
| Depreciation & amort. | −0 | −24 | — | — | — |
| EBIT | 691 | 680 | 885 | 751 | 953 |
| Net financials | −3 | −3 | 7 | 5 | −75 |
| Profit before tax | 539 | 677 | 941 | 755 | 878 |
| Tax | −113 | −143 | −196 | −157 | −198 |
| Net profit | 426 | 535 | 746 | 599 | 679 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 336 | 1 249 | 1 354 | 1 269 | 1 347 |
| Equity | 495 | 629 | 875 | 673 | 753 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 591 | 370 | 279 | 396 | 395 |
| Total debt | 591 | 370 | 279 | 396 | 395 |
EBITDA margin
35.0%
This company
15.8%
Market median
+122% vs market
20212025
Equity ratio
55.9%
This company
38.2%
Market median
+46% vs market
20212025
Return on equity
90.3%
This company
18.4%
Market median
+391% vs market
20212025
Net profit margin
24.9%
This company
8.1%
Market median
+207% vs market
20212025
Asset turnover
2.02×
This company
1.12×
Market median
+80% vs market
20212025
Debt / equity
0.79×
This company
0.62×
Market median
+27% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Abbibr doc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ibrahim Abbas Abdi | Board of Directors | 0 companies |
| Abdirahman Ahmed Jelle | Deputy Board Member | 0 companies |
| Farhia Hassan Abrikar | Deputy Board Member | 0 companies |